These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36656220)

  • 21. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.
    Kulkarni R; Pujari SS; Gupta D; Ojha P; Dhamne M; Bolegave V; Dhonde P; Soni A; Adwani S; Diwan A; Duberkar D; Batra D; Deshpande R; Aurangabadkar K; Palasdeokar N
    J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106231. PubMed ID: 34890962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
    Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
    Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-associated mucormycosis presenting to the Emergency Department-an observational study of 70 patients.
    Ramaswami A; Sahu AK; Kumar A; Suresh S; Nair A; Gupta D; Chouhan R; Bhat R; Mathew R; Majeed JA; Aggarwal P; Nayer J; Ekka M; Thakar A; Singh G; Xess I; Wig N
    QJM; 2021 Nov; 114(7):464-470. PubMed ID: 34254132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
    Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
    Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study.
    Tavakolpour S; Irani S; Yekaninejad MS; Alimardi M; Hasibi M; Abdollahi H; Kazemi MA; Lotfi M; Shahbazian H; Nazemian Yazdi NA; Samimiardestani S; Firouzifar M; Farahbakhsh F; Mirzaee Goodarzi M; Feiz F; Salehinia F
    Mycopathologia; 2022 Dec; 187(5-6):469-479. PubMed ID: 36202942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
    Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
    Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
    Yadav S; Bs N; Ak S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary approach in diagnosis and treatment of COVID-19-associated mucormycosis: a description of current reports.
    Gogineni H; So W; Mata K; Greene JN
    Egypt J Intern Med; 2022; 34(1):58. PubMed ID: 35911783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhino-orbito-cerebral mucormycosis: an epidemic in a pandemic.
    Sekaran A; Patil N; Sabhapandit S; Sistla SK; Reddy DN
    IJID Reg; 2022 Mar; 2():99-106. PubMed ID: 35721429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Study of Correlation of Lipid Parameters with Clinical Profile, Staging and Onset of Rhino Orbito Cerebral Mucormycosis Covid 19 Pandemic.
    V V; St K
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
    Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
    Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
    Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
    Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
    Mehfooz S; Mehrotra N; Usmani T; Raj V
    Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucormycosis infection associated with global COVID-19 pandemic - an institutional histopathological study.
    Keerthika R; Narwal A; Kamboj M; Devi A; Anand R; N S; Singh V; Agarwal V; Gupta A
    Med Oral Patol Oral Cir Bucal; 2023 Mar; 28(2):e99-e107. PubMed ID: 36806020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhinocerebral mucormycosis: A clinicopathological analysis of COVID-19-associated mucormycosis.
    Bahal N; Piyush AR; Kala PS; Dogra S; Thapliyal N
    J Family Med Prim Care; 2024 Aug; 13(8):3257-3263. PubMed ID: 39228572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period.
    Cherian LM; Varghese L; Rupa V; Bright RR; Abraham L; Panicker R; R N; Peter J; Nayak A; Shyam A; Varghese GM; Manesh A; Karuppusami R; George K; George T; Lenin A; Hansdak SG; I R; Michael JS; Ninan M; Thomas M; Kurian R; Mammen S; Kurien R
    Rhinology; 2022 Dec; 60(6):427-434. PubMed ID: 36150158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.